162 related articles for article (PubMed ID: 37477781)
21. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
[TBL] [Abstract][Full Text] [Related]
22. Treatment of minute medullary thyroid carcinoma in multiple endocrine neoplasia 2A families first diagnosed by DNA analysis of RET proto-oncogene mutations: a case report.
Yamashita T; Lihara M; Okamoto J; Kanbe M; Ito Y; Kawakami M; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Feb; 27(1):42-5. PubMed ID: 9070340
[TBL] [Abstract][Full Text] [Related]
23. Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening.
Machens A; Lorenz K; Dralle H
J Clin Endocrinol Metab; 2013 Feb; 98(2):E336-45. PubMed ID: 23284010
[TBL] [Abstract][Full Text] [Related]
24. Coexistence of MEN 2A and papillary thyroid carcinoma and a recurrent pheochromocytoma 23 years after surgery: report of a case and a review of the Japanese literature.
Oishi S; Sasaki M; Sato T; Isogai M
Jpn J Clin Oncol; 1995 Aug; 25(4):153-8. PubMed ID: 7666591
[TBL] [Abstract][Full Text] [Related]
25. Patients with RET D631Y mutations most commonly present with pheochromocytoma and not medullary thyroid carcinoma.
Elston MS; Meyer-Rochow GY; Holdaway I; Conaglen JV
Horm Metab Res; 2012 May; 44(5):339-42. PubMed ID: 22274720
[TBL] [Abstract][Full Text] [Related]
26. Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation.
Ospina NS; Maraka S; Donegan D; Morris JC
Thyroid; 2017 Oct; 27(10):1332-1334. PubMed ID: 28747092
[TBL] [Abstract][Full Text] [Related]
27. [Multiple endocrine neoplasia type 2A].
Juodele L; Krasauskas V; Zindzius A; Juozaityte E; Pundzius J
Medicina (Kaunas); 2006; 42(3):215-24. PubMed ID: 16607064
[TBL] [Abstract][Full Text] [Related]
28. Multiple endocrine neoplasia 2A (MEN 2A) syndrome.
Breza J; Breza J
Bratisl Lek Listy; 2018; 119(2):120-125. PubMed ID: 29455549
[TBL] [Abstract][Full Text] [Related]
29. [Clinical characteristics of multiple endocrine neoplasia].
Conte-Devolx B; Niccoli P;
Bull Acad Natl Med; 2010 Jan; 194(1):69-78; discussion 78-9. PubMed ID: 20669560
[TBL] [Abstract][Full Text] [Related]
30. Surgical approaches in hereditary endocrine tumors.
Iacobone M; Citton M; Viel G; Schiavone D; Torresan F
Updates Surg; 2017 Jun; 69(2):181-191. PubMed ID: 28455835
[TBL] [Abstract][Full Text] [Related]
31. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
32. [Multiple endocrine neoplasia type 2A in a family].
Hircsu I; Gazdag A; Bodor M; Berta E; Andrási M; Kanyári Z; Győry F; Barna S; Bhattoa HP; Nagy B; Nagy VE; Erdei A
Orv Hetil; 2020 Jan; 161(2):75-79. PubMed ID: 31902232
[TBL] [Abstract][Full Text] [Related]
33. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
[TBL] [Abstract][Full Text] [Related]
34. Surgical management of MEN-1 and -2: state of the art.
Akerström G; Stålberg P
Surg Clin North Am; 2009 Oct; 89(5):1047-68. PubMed ID: 19836484
[TBL] [Abstract][Full Text] [Related]
35. Over-representation of the G12S polymorphism of the SDHD gene in patients with MEN2A syndrome.
Lendvai N; Tóth M; Valkusz Z; Bekő G; Szücs N; Csajbók E; Igaz P; Kriszt B; Kovács B; Rácz K; Patócs A
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):85-9. PubMed ID: 22584711
[TBL] [Abstract][Full Text] [Related]
36. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.
Iihara M; Yamashita T; Okamoto T; Kanbe M; Yamazaki K; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Jun; 27(3):128-34. PubMed ID: 9255265
[TBL] [Abstract][Full Text] [Related]
37. [Surgical aspects of multiple endocrine neoplasia type 2].
Lorenz K; Satiroglu I
Ther Umsch; 2020 Nov; 77(9):457-465. PubMed ID: 33146093
[TBL] [Abstract][Full Text] [Related]
38. [The clinical characteristics and therapy of multiple endocrine neoplasia type 2].
Xie Y; Li HZ; Rong S; Zhu Y
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1096-9. PubMed ID: 15498294
[TBL] [Abstract][Full Text] [Related]
39. Unilateral laparoscopic adrenalectomy followed by contralateral retroperitoneoscopic partial adrenalectomy in a patient with multiple endocrine neoplasia type 2a syndrome.
Mugiya S; Suzuki K; Saisu K; Fujita K
J Endourol; 1999 Mar; 13(2):99-104; discussion 104-6. PubMed ID: 10213103
[TBL] [Abstract][Full Text] [Related]
40. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
